Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Jonathan G, Leung"'
Publikováno v:
Schizophrenia, Vol 10, Iss 1, Pp 1-6 (2024)
Externí odkaz:
https://doaj.org/article/e43db5b7af15427e97a09dc84757dc57
Publikováno v:
Mental Health Clinician, Vol 14, Iss 3, Pp 220-223 (2024)
Clozapine is primarily metabolized via cytochrome P450(CYP)1A2 and to a lesser extent CYP3A4, CYP2C19, and CYP2D6. Metabolic inhibitors of clozapine, such as fluvoxamine and ciprofloxacin, are important to recognize to avoid adverse drug events. Estr
Externí odkaz:
https://doaj.org/article/da9e607c460f488c8ce931793843448d
Autor:
Matthew Nuebel, PharmD, Jonathan G. Leung, PharmD, Christopher Hughes, PhD, Ian McGrane, PharmD
Publikováno v:
Mental Health Clinician, Vol 14, Iss 3, Pp 204-211 (2024)
Introduction Clozapine is the only antipsychotic approved for treatment-resistant schizophrenia, but without appropriate monitoring, it can be associated with potentially fatal outcomes. An International Adult Clozapine Titration Guideline categorize
Externí odkaz:
https://doaj.org/article/bbc5395704714d0ea55243e6ca4f78c9
Autor:
Nicolas A. Nuñez, Brandon J. Coombes, Lindsay Melhuish Beaupre, Aysegul Ozerdem, Manuel Gardea Resendez, Francisco Romo-Nava, David J. Bond, Marin Veldic, Balwinder Singh, Katherine M. Moore, Hannah K. Betcher, Simon Kung, Miguel L. Prieto, Manuel Fuentes, Mete Ercis, Alessandro Miola, Jorge A. Sanchez Ruiz, Gregory Jenkins, Anthony Batzler, Jonathan G. Leung, Alfredo Cuellar-Barboza, Susannah J. Tye, Susan L. McElroy, Joanna M. Biernacka, Mark A. Frye
Publikováno v:
Translational Psychiatry, Vol 14, Iss 1, Pp 1-5 (2024)
Abstract There is increasing interest in individualizing treatment selection for more than 25 regulatory approved treatments for major depressive disorder (MDD). Despite an inconclusive efficacy evidence base, antidepressants (ADs) are prescribed for
Externí odkaz:
https://doaj.org/article/30895815cfaa4cdd8a949170cc6615ae
Publikováno v:
Mental Health Clinician, Vol 13, Iss 6, Pp 276-288 (2023)
The concept of ethnopsychopharmacology aims to predict or explain the pharmacologic response to psychiatric medications based on the influence of biologic and nonbiologic factors. Interactions involving these factors are complex and influence patient
Externí odkaz:
https://doaj.org/article/df52d9314d224714a41f06c32402d748
Autor:
Dylan L. Kosaski, PharmD, Kristin C. Cole, Jessica A. Wright, Razan M. El Melik, PharmD, Simon Kung, MD, Wayne T. Nicholson, MD, PharmD, Jonathan G. Leung, PharmD
Publikováno v:
Mental Health Clinician, Vol 13, Iss 6, Pp 303-310 (2023)
Introduction: Although there are studies assessing reasons for antidepressant discontinuation, little is known about the impact of sex differences or cytochrome P450 phenotypes. Our objective is to assess discontinuation rates between males and femal
Externí odkaz:
https://doaj.org/article/f5adae5ad7144ff49dbe80593e6fe2d3
Autor:
Joseph C. Osborne, II, PharmD, Susan E. Horsman, PharmD, BCPS, Kristin C. Mara, MS, Thomas C. Kingsley, MD, MPH, Robert W. Kirchoff, MD, Jonathan G. Leung, PharmD, BCPS, BCPP
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 1, Pp 1-9 (2022)
Objective: To investigate medication factors and patient characteristics associated with readmissions following alcohol-related hospitalizations. Patients and Methods: Adult patients admitted from September 1, 2016, through August 31, 2019, who had a
Externí odkaz:
https://doaj.org/article/1145aaeddf1848cc9377731d5139c807
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/b093205a789747fca685c1a710f815d0
Autor:
Jonathan G. Leung, Prasanna P. Narayanan, Matej Markota, Nathaniel E. Miller, Kemuel L. Philbrick, M. Caroline Burton, Robert W. Kirchoff
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
ObjectiveTo survey barriers in prescribing naltrexone for alcohol use disorder.MethodsA 12-question survey related to naltrexone prescribing patterns, perceptions, and knowledge was sent to 770 prescribers in the departments of internal medicine, fam
Externí odkaz:
https://doaj.org/article/2b742d5323e446baa5f40ad6c033bf77
Autor:
Ruth E. Bates, MD, Jonathan G. Leung, PharmD, RPh, Robert J. Morgan, III, MD, Karen M. Fischer, MPH, Kemuel L. Philbrick, MD, Simon Kung, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 5, Pp 542-549 (2020)
Objective: To evaluate the efficacy and safety of a fixed-dose gabapentin taper protocol for alcohol withdrawal in hospitalized patients. Patients and Methods: We retrospectively identified patients admitted to the hospital from January 1, 2016, to A
Externí odkaz:
https://doaj.org/article/76c61b0ffb484cf584fbe142eeafd2cd